Stay updated on First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New date stamps and results-posting status were added (e.g., 'No Results Posted' on 2026-03-03), and older entries were removed. The overall study details, eligibility criteria, and planned interventions remain unchanged.
    Difference
    0.2%
    Check dated 2026-03-05T00:22:09.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    - Revision: v3.4.2 has been added. The government funding notice and Revision: v3.4.1 banner have been removed; no study content or eligibility information was changed.
    Difference
    0.3%
    Check dated 2026-02-11T12:41:16.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Results status updated from No Results Posted to Results Submitted, and the page revision shows Revision: v3.4.1. A government-funding status notice about NIH operations is also displayed.
    Difference
    0.3%
    Check dated 2026-02-04T10:11:58.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    UI updates include showing a glossary and new metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0) along with the removal of older labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T05:00:07.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Page footer revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T01:16:06.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The locations section has been expanded to list more trial sites across the US, Canada, Australia, Europe, and Asia, organized by region. This makes it easier for potential participants to find a nearby site and assess eligibility.
    Difference
    1%
    Check dated 2025-12-23T09:55:19.000Z thumbnail image

Stay in the know with updates to First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.